Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · IEX Real-Time Price · USD
3.490
-0.080 (-2.24%)
Mar 28, 2024, 10:31 AM EDT - Market open

Conduit Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Selling, General & Admin
3.052.89
Research & Development
0.040.03
Other Operating Expenses
0.070.26
Operating Expenses
3.163.17
Operating Income
-3.16-3.17
Other Expense / Income
1.730.48
Pretax Income
-4.89-3.66
Net Income
-4.89-3.66
Shares Outstanding (Basic)
2,0001,000
Shares Outstanding (Diluted)
2,0001,000
Shares Change
100.00%-
EPS (Basic)
-2444.00-3657.00
EPS (Diluted)
-2444.00-3657.00
Free Cash Flow
-2.27-2.15
Free Cash Flow Per Share
-0.00-0.00
EBITDA
-4.89-3.66
EBIT
-4.89-3.66
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).